Review of Emerging Treatments for Vitiligo an immune mediated dz that affects QOL & has psychosocial impact. JAKi only ruxolitinib is FDA-approved, but Tofa & Bari show promise. Emerging therapies include simvastatin, afamelanotide, and metformin https://t.co/Rp2yYx6SyZ https://t.co/pBo1IDe8pQ
Links:
Future of Vitiligo Treatment: Emerging Therapies, Impact on Quality of Life
https://buff.ly/o1KU3AH
Jun-05-2025
